Navigation Links
MEI Pharma Announces Retirement Of Chairman Bryan Williams From Board Of Directors And Appointment Of Christine White As Lead Director
Date:1/30/2013

lignancies such as myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Results from a pilot Phase II clinical trial of Pracinostat in combination with azacitidine in patients with advanced MDS showed an overall response rate (CR+CRi+PR) of 90% (nine out of 10), including eight complete responses. The Company plans to initiate a randomized, placebo-controlled Phase II trial of Pracinostat in combination with azacitidine in patients with MDS by June 2013. In addition, MEI Pharma is developing two drug candidates derived from its isoflavone-based technology platform, ME-143 and ME-344. For more information, go to www.meipharma.com.

Under U.S. law, a new drug cannot be marketed until it has been investigated in clinical trials and approved by the FDA as being safe and effective for the intended use. Statements included in this press release that are not historical in nature are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You should be aware that our actual results could differ materially from those contained in the forward-looking statements, which are based on management's current expectations and are subject to a number of risks and uncertainties, including, but not limited to, our failure to successfully commercialize our product candidates; costs and delays in the development and/or FDA approval, or the failure to obtain such approval, of our product candidates; uncertainties or differences in interpretation in clinical trial results; our inability to maintain or enter into, and the risks resulting from our dependence upon, collaboration or contractual arrangements necessary for the development, manufacture, commercialization, marketing, sales and distribution of any products; competitive factors; our inability to protect our patents or proprietary rights and obtain necessary rights to third party patents and inte
'/>"/>

SOURCE MEI Pharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
3. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
6. Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
8. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
9. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
10. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
11. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... March 27, 2015  The quality function within the ... products meet quality standards at every stage of the ... quality leaders also have the challenge of balancing quality ... Those who don,t effectively balance these priorities risk funding ... marketplace failure and regulatory scrutiny. For the ...
(Date:3/27/2015)... , March 27, 2015 Object recognition technology ... visually impaired and elderly. The VelaSense ® ... to lead more independent, productive and fulfilling lives. VelaSense ... will allow users to identify objects from a one ... as create customized object databases for personal use. ...
(Date:3/27/2015)... - Russell Williams , President of ... 2015-2016 Quebec Budget, noting the fiscal discipline and the ... However, the association is concerned about the decline of ... intent to strive for a balanced budget this year, ... Quebec,s economic development is encouraging," said Mr. ...
Breaking Medicine Technology:New Medical Device Quality Study Finds Regulatory Environment is Boosting Quality Spending, Especially for Large Companies 2VelaSense Object Recognition Technology for the Blind was unveiled at Baruch College's CCVIP 8th Annual Conference 2Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 2Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 3
... Inc. (OTC Bulletin Board: NEPH ), a ... therapeutic applications, infection control, and water purification, today announced ... previously announced rights offering to its existing stockholders was ... and Exchange Commission. Under the terms of ...
... 2011 Associates of Cape Cod, Inc., (ACC) ... DETECTION SYSTEM incorporating the enhanced Pyrochrome® chromogenic reagent ... tube reader. This system offers our customers diverse ... ACC,s enhanced Pyrochrome® is a versatile, quantitative reagent ...
Cached Medicine Technology:Nephros Rights Offering Registration Statement Declared Effective 2Nephros Rights Offering Registration Statement Declared Effective 3Nephros Rights Offering Registration Statement Declared Effective 4New Chromogenic Endotoxin Detection System 2
(Date:3/27/2015)... Operatic contenders and their avid audience will be ... universally acclaimed baritone Sherrill Milnes will be overseeing the ... The Merion in Evanston. The event is the culmination ... singers from around the country. “This is a highly-anticipated ... talent in the country,” said Margaret Gergen, executive director ...
(Date:3/27/2015)... 2015 Approximately 300 advocates participated ... Coalition Lobby Day to lobby for physical education, ... (SHIP). Everlast Climbing was especially interested in ... which would strengthen physical education programs by adopting ... other measures to strengthen physical education in schools. ...
(Date:3/27/2015)... 2015 Airy Jeanine is a rising ... music video for her debut song “Mama’s Girl”, launched ... and abstract styling effects, the thematic video for the ... Vimeo, and assorted outlets. It will be integral in ... expanding full-scale marketing strategy. The video promotion campaign spearheaded ...
(Date:3/27/2015)... Newport, RI (PRWEB) March 27, 2015 April ... civil war – the Sesquicentennial. To honor America’s bloodiest war ... the Fort Adams Trust presents A Tribute to the Civil ... 7:00 PM, Friday, April 17, 2015, at the Jane Pickens ... Williams, noted Civil War-Lincoln scholar, will serve as the master ...
(Date:3/27/2015)... March 27, 2015 The Florida Center ... Brain Cancer Cure (ABC2), awarded $350,000 to support brain ... Florida, The Scripps Research Institute and H. Lee Moffitt ... studies with a clear development path and potential to ... the near future. , The awards fund research ...
Breaking Medicine News(10 mins):Health News:Opera Idol Competition At The Merion In Evanston 2Health News:Everlast Climbing Advocates to Strengthen Physical Education in Minnesota Schools 2Health News:Airy Jeanine Releases ‘’Mama’s Girl” Official Music Video 2Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 2Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 3Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 4Health News:The Florida Center for Brain Tumor Research and Accelerate Brain Cancer Cure Award $350,000 to Florida-Based Researchers 2Health News:The Florida Center for Brain Tumor Research and Accelerate Brain Cancer Cure Award $350,000 to Florida-Based Researchers 3
... say that they have developed a faster, less expensive ... stretches of DNA. The development of the new technique ... mutant genes, but also from mutations of other DNA ... occur as a consequence of deleting non-gene DNA sequences, ...
... is an eye disease that can cause blindness and ... get past the blood-brain barrier making it an ... an engineering professor with appointments in UCFs Advanced Materials ... ,Seal and his colleagues from North Dakota ...
... suggests that playing with candy cigarettes may favorably set ... smokers . , The study, reported in ... a nationally representative sample of 25,887 US adults, the ... in current and former smokers vs. 22% in never ...
... Kingdom have found that patients with COPD, or chronic ... researchers also found that those COPD patients with osteoporosis, ... greater arterial stiffness. These premature signs of aging may ... cardiovascular disease. ,Their research results appear in ...
... Cancer Center researchers helps explain how memory T cells ... shows lymph nodes are not just organs where immune ... where a major fight against the spread of an ... many viruses, the body becomes immune (protected) from recurrence ...
... pair and played hide-and-seek Monday evening in a relatively rare ... ,As the cloud blanket gave way to an ... fields, parks and from top of their houses - had ... of the Nehru Planetarium here, assisted by over a dozen ...
Cached Medicine News:Health News:Boffins Develop New Technique to Hunt Illness-causing Mutants in Non-gene DNA 2Health News:Nanoparticle in the Treatment of Glaucoma 2Health News:The Danger in Candy Cigarettes 2Health News:Premature Vascular and Bone Changes Occur in COPD Patients 2Health News:Premature Vascular and Bone Changes Occur in COPD Patients 3Health News:Memory T Cells Protect the Body from Viruses 2
Ambion's barrier tips prevent cross-contamination of samples by means of an aerosol filter. They are RNase- and DNase-free and are ideal for handling RNA, PCR applications, and for working with radio...
200 L, Bulk, clear Recommended for 20, 25, 50, 100 and 200 L pipettes. ...
Its generous filter placement, MicroPoint design, and reference marks at 10, 50, and 100 ul make this ART tip ideal for many 200 ul pipettors....
... tips, microfuge tubes and PCR tubes. ... RNase- and DNase-free. Tubes have a ... 120°C. Available in a variety of ... a low binding surface. PCR Tubes ...
Medicine Products: